A study of workers in Denmark showed a 17.3 percent decline in long-term sick leave among those who were treated with Ozempic, according to results published this month in a National Bureau of Economic Research working paper.
View on Bluesky
Source: at://did:plc:kkf4naxqmweop7dv4l2iqqf5/app.bsky.feed.generator/news-2-0
Author: The Washington Post (@washingtonpost.com)
View on Bluesky
Source: at://did:plc:kkf4naxqmweop7dv4l2iqqf5/app.bsky.feed.generator/news-2-0
Author: The Washington Post (@washingtonpost.com)
